skip to Main Content

IBT to expand development of its S. aureus vaccine, IBT-VO2

  • August 15, 2019

(BOSTON, MA) –– CARB-X, a global partnership led by Boston University, is awarding Integrated Biotherapeutics (IBT) of Rockville, Maryland, USA, $1.6 million to expand the development of its vaccine against Staphylococcus aureus,  including  Methicillin-resistant Staphylococcus aureus (MRSA) superbugs, so that…

Read More

ID Week

  • August 14, 2019

IDWeek 2019 Annual Conference October 2 - October 6 Attendees include Richard Alm, CARB-X Alliance Director. IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical…

Read More
Back To Top
×Close search
Search